Osteosarcoma
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
Advancing therapy for osteosarcoma
Improving the survival of patients with osteosarcoma has long proved challenging, although
the treatment of this disease is on the precipice of advancement. The increasing feasibility of …
the treatment of this disease is on the precipice of advancement. The increasing feasibility of …
Advances on immunotherapy for osteosarcoma
S Yu, X Yao - Molecular Cancer, 2024 - Springer
Osteosarcoma is the most common primary bone cancer in children and young adults.
Limited progress has been made in improving the survival outcomes in patients with …
Limited progress has been made in improving the survival outcomes in patients with …
Osteosarcoma: a review of current and future therapeutic approaches
X Zhao, Q Wu, X Gong, J Liu, Y Ma - Biomedical engineering online, 2021 - Springer
Osteosarcoma (OS) is the most common primary bone malignancy that affects children and
young adults. OS is characterized by a high degree of malignancy, strong invasiveness …
young adults. OS is characterized by a high degree of malignancy, strong invasiveness …
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
C Xue, G Li, J Lu, L Li - Signal transduction and targeted therapy, 2021 - nature.com
Circular RNAs (circRNAs), covalently closed noncoding RNAs, are widely expressed in
eukaryotes and viruses. They can function by regulating target gene expression, linear RNA …
eukaryotes and viruses. They can function by regulating target gene expression, linear RNA …
Current and future therapeutic approaches for osteosarcoma
DJ Harrison, DS Geller, JD Gill, VO Lewis… - Expert review of …, 2018 - Taylor & Francis
Introduction: Current treatment of osteosarcoma includes surgical resection of all gross
disease in conjunction with systemic chemotherapy to control micro-metastatic disease. This …
disease in conjunction with systemic chemotherapy to control micro-metastatic disease. This …
Osteosarcoma and metastasis
Osteosarcoma is the most common primary bone malignancy in adolescents. Its high
propensity to metastasize is the leading cause for treatment failure and poor prognosis …
propensity to metastasize is the leading cause for treatment failure and poor prognosis …
Update on osteosarcoma
Abstract Purpose of Review Osteosarcoma (OSA) is the most common primary tumor of
bone, mainly affecting children and adolescents. Here we discuss recent advances in …
bone, mainly affecting children and adolescents. Here we discuss recent advances in …
A unified therapeutic–prophylactic tissue‐engineering scaffold demonstrated to prevent tumor recurrence and overcoming infection toward bone remodeling
Y Huang, X Zhai, T Ma, M Zhang, H Yang… - Advanced …, 2023 - Wiley Online Library
Osteosarcoma occurs in children and adolescents frequently and leads to a high fatality rate.
Although surgical resection is the most common methods in clinic, patients always suffer …
Although surgical resection is the most common methods in clinic, patients always suffer …
Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies
I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …